m+Medelevator.RU
← Поиск публикаций
Cochlear implants international · 2025

MRI evaluation of the Osia® 2 hearing implant with OSI300 actuator: insights from a full-head cadaver model.

СтатьяОценочное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Diosi Beata, Molnar Fiona Anna, Bere Zsofia, Csomor Angela, Kaszas Imre, Toth Zoltan, Posta Balint, Nogradi Antal, Kincses Zsigmond Tamas, Rovo Laszlo, Perenyi Adam

Аннотация

OBJECTIVES: Our study aimed to evaluate the impact of magnetic resonance (MR) image artefacts caused by the OSI300 implant system on the ability to visualize specific cranial structures.

METHODS: One cadaveric head was unilaterally implanted and underwent MR imaging in 1.5 and 3 Tesla magnetic fields under the following conditions: (1) no device, (2) Cochlear BI300 plus OSI300 with magnet, (3) Cochlear BI300 plus OSI300 with spacer, (4) Cochlear BI300 plus OSI300 without magnet or spacer using the institutional head and inner ear protocol and with metal artefact reduction (MAVRIC SL). Blinded image scoring was performed independently by three radiologists.

RESULTS: Excluding diffusion and susceptibility weighted imaging (DWI and SWI) anatomical structures contralateral to the OSI300 implant were highly visible in all conditions. Artefact size was clearly improved after magnet removal and with metal artefact reduction technique.

DISCUSSION: The OSI300 system produces image artefacts in both 1.5 and 3.0 Tesla MR imaging and, as previous research has reported, with the coil magnet removed, offers the least amount of distortion and artefact.

CONCLUSION: While certain sequences such as DWI, FLAIR and SWI showed notably reduced diagnostic value, the MAVRIC SL sequences proved to reduce implant artefact resulting in diagnostic quality examinations.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты